Add BrightSurf on Google Email

University of California - Los Angeles Health Sciences


Researchers may have found a way to mitigate or eliminate excessive scarring during wound healing

A study published in Nature Communications identifies fibromodulin as a protein that forms a complex with interleukin 1β to stop myofibroblasts from forming excessive scar tissue. This finding could lead to a new way to reduce or prevent excessive scarring, benefiting patients recovering from surgery, injuries, or burns.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Communications·TypeExperimental study·DateApr 30, 2025

Nearly one-quarter of e-Scooter injuries involved substance impaired riders

A UCLA study found that nearly one-quarter of e-scooter-related injuries involved substance-impaired riders, who experienced almost double the risk of traumatic brain injuries compared to non-impaired patients. The study also highlights increased hospital costs for these patients, averaging $4,600 per case.

SourceUniversity of California - Los Angeles Health Sciences·JournalThe American Surgeon·TypeData/statistical analysis·DateApr 29, 2025

Telemedicine had an impact on carbon emissions equivalent to reducing up to 130,000 car trips each month in 2023

New UCLA-led research finds that telemedicine use in 2023 reduced monthly CO2 emissions by the equivalent of 61,000 to 130,000 gas powered vehicles. This modest but noticeable impact on the environment could have policy implications for US healthcare delivery.

SourceUniversity of California - Los Angeles Health Sciences·JournalThe American Journal of Managed Care·TypeData/statistical analysis·DateApr 22, 2025

AACR: Advancements in combination therapies for liver and pancreatic cancers, organoid-based platform for personalized head and neck cancer treatment, liquid biopsies for cancer detection and more

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center are presenting new findings on combination therapies for liver and pancreatic cancers, including a new organoid model for personalized head and neck cancer treatment. Additionally, they are discussing the potential of liquid biopsies for cancer detection and monitoring.

UCLA researchers identify precision medicine approach for preventing kidney failure

Researchers have identified a potential precision medicine approach to prevent chronic kidney disease progression by targeting type 5 collagen, a minor component of scar tissue. A repurposed anti-cancer drug, Cilengitide, has been shown to slow kidney scarring and disease progression in high-risk individuals.

SourceUniversity of California - Los Angeles Health Sciences·JournalScience Translational Medicine·DateApr 9, 2025

Test predicts which patients with prostate cancer are most likely to develop long-term side effects from radiation therapy

A UCLA study validates the predictive power of PROSTOX, a genetic test that uses microRNAs to identify patients at higher risk of developing long-lasting urinary side effects from radiation therapy. The test helps doctors and patients choose safer treatment options, reducing the burden of long-term complications.

SourceUniversity of California - Los Angeles Health Sciences·JournalClinical Cancer Research·DateApr 7, 2025

E-cigarettes linked to lower cardiac risks compared to tobacco cigarettes in people with HIV

Researchers found that electronic cigarettes have a lower likelihood of causing changes associated with atherogenesis, compared to tobacco cigarettes, among people living with HIV. This suggests switching to e-cigarettes could be a promising harm reduction strategy for this vulnerable population.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of the American Heart Association·TypeRandomized controlled/clinical trial·DateMar 19, 2025

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

A new study confirms that a shorter, higher-dose-per-day radiation course is as effective as conventional radiotherapy for treating early-stage prostate cancer without increasing side effects. The study found similar cancer control rates and fewer gastrointestinal issues with the new approach.

Dr. Theodore Scott Nowicki awarded $4.5M NCI grant to advance next generation of cellular immunotherapies for solid tumors

Dr. Nowicki's team has engineered 'supercharged' T cells that produce extra TNF-alpha to boost cancer-fighting ability, offering a potentially more precise and toxic-free treatment option. The new funding will help test these enhanced T cells in preclinical models to evaluate their effectiveness.

Socioeconomically disadvantaged people still underusing emergency department services in the wake of the COVID pandemic

A study found that socioeconomically disadvantaged patients used emergency departments less for non-avoidable visits, despite an overall rebound in ED use by 2022. This trend reverses pre-pandemic increases in ED utilization among Medicaid and dual-eligible patients.

SourceUniversity of California - Los Angeles Health Sciences·JournalHealth Affairs·TypeData/statistical analysis·DateMar 11, 2025

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

A new study suggests that chronic stress and an unhealthy diet may work together to fuel the early development of pancreatic cancer. Researchers found that both stress-related neurotransmitters and obesity-related hormones activate a protein called CREB, which is linked to cancer cell growth.

SourceUniversity of California - Los Angeles Health Sciences·JournalMolecular Cancer Research·DateMar 10, 2025

Ivermectin, hydroxychloroquine prescriptions during the COVID-19 pandemic soared far above pre-pandemic levels

US outpatient prescriptions for ivermectin and hydroxychloroquine increased significantly during the COVID-19 pandemic, with usage being three times higher among adults aged 65 and older. The study's findings highlight the need for policy reforms to combat misinformation and mistrust in scientific institutions.

SourceUniversity of California - Los Angeles Health Sciences·JournalHealth Affairs·TypeData/statistical analysis·DateFeb 20, 2025

Paxlovid’s impact on hospitalization and death in COVID-vaccinated older adults far weaker than previously thought

New UCLA-led research finds that Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults. The study suggests that Paxlovid's potential effect on COVID-19 hospitalization in vaccinated older adults is four times weaker than originally reported.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA·TypeData/statistical analysis·DateFeb 20, 2025

Emergency clinicians increase prescriptions of buprenorphine, effectively help patients get started on the path to recovery

A study found that emergency clinician prescribing of buprenorphine increased in California, leading to more patients starting treatment for opioid use disorder. The efforts were successful in getting patients started, with at least one in three filling a second prescription within 40 days.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA·TypeObservational study·DateFeb 19, 2025

Telehealth may be closing the care gap for people with substance use disorder in rural areas

A recent study found that telehealth is closing the care gap for people with substance use disorder in rural areas, but those covered by Medicaid managed care have lower access to this treatment. Rural individuals experienced the greatest overall increase in substance use disorder treatment among all populations studied.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeData/statistical analysis·DateFeb 12, 2025

Mystery solved: New study reveals how DNA repair genes play a major role in Huntington's disease

Researchers discovered that mismatch repair genes are critical in eliciting damages to neurons vulnerable to Huntington's disease, triggering downstream pathologies and motor impairment. Targeting these genes may offer novel therapeutic approaches, including improving locomotor and gait deficits and reducing neuronal cell death.

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

A recent study published in Lancet Oncology reveals a significant link between early side effects from radiation therapy for prostate cancer and long-term complications. Men who experience moderate acute urinary or bowel side effects during treatment are nearly twice as likely to develop late urinary or bowel issues, respectively. This...

D-CARE study finds no differences between dementia care approaches on patient behavioral symptoms or caregiver strain

The D-CARE study found no differences in patient behavioral symptoms or caregiver strain between health system and community-based care approaches. However, comprehensive care improved caregiver self-efficacy, which remained consistent throughout the 18-month period.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA·TypeRandomized controlled/clinical trial·DateJan 29, 2025

Medicaid-insured heart transplant patients face higher risk of post-transplant complications

A new study highlights the link between socioeconomic disadvantage and poorer survival rates after heart transplantation in Medicaid-insured patients. The research found that these patients had a higher likelihood of developing cardiac allograft vasculopathy (CAV), a condition affecting transplanted hearts and limiting long-term survival.

SourceUniversity of California - Los Angeles Health Sciences·JournalThe Annals of Thoracic Surgery·TypeData/statistical analysis·DateJan 24, 2025

Tumor-secreted protein may hold the key to better treatments for deadly brain tumor, study finds

A study suggests targeting endocan, a protein produced by endothelial cells in blood vessels, could slow tumor growth and make glioblastoma more vulnerable to existing treatments. The discovery may lead to new strategies to combat glioblastoma, which has an average lifespan of just 12-15 months.

Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases

A new study found that nearly half of high-risk prostate cancer patients have metastatic disease when evaluated with advanced PSMA-PET imaging, suggesting traditional imaging may underestimate cancer spread. This challenge the interpretation of previous studies like EMBARK trial, and support the inclusion of PSMA-PET for patient select...

Multilingualism improves crucial cognitive functions in autistic children

A new study reveals multilingualism enhances executive function skills, including focus, understanding perspectives, communication, and reduces repetitive behaviors in both autistic and non-autistic children. Parents of multilingual households report stronger overall executive function compared to mono-lingual households.

SourceUniversity of California - Los Angeles Health Sciences·JournalAutism Research·TypeObservational study·DateJan 3, 2025

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

A new study found that emergency department physicians differ in their likelihood of hospitalizing patients, with those who admit more patients being discharged sooner but not less likely to die. The study suggests that differences in physician decision-making drive these variations, rather than patient health.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateDec 23, 2024

Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals

The study highlights the need for targeted incentives to expand hospital-at-home programs to smaller, rural, and non-teaching hospitals. The research found that adoption of these programs remains concentrated among larger, urban, not-for-profit, and academic hospitals.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA·TypeData/statistical analysis·DateDec 23, 2024